Primary varicella zoster virus (VZV) infection usually affects children and young adults. Symptoms in immunocompetent patients are generally limited to cutaneous manifestations. Pulmonary and neurological manifestations of primary VZV infection are extremely rare and usually described in immunocompromised patients. Acute Disseminated Encephalomyelitis (ADEM), an immune-mediated inflammatory demyelination event often occurring after a viral infection, has been rarely described as occurring after primary VZV infection. We present a case of a previously healthy adult presenting with primary VZV infection complicated by pneumonitis and neurological involvement. To our knowledge, no similar cases were previously described.
Varicella zoster virus (VZV), a DNA virus for whom humans are the only known reservoir, typically manifests as a self-limited cutaneous disease in immunocompetent hosts 1. It is a member of the Herpesviridae family, and shares structural similarities with other members of this family 2. Following infection by the respiratory route, viral replication and viremia occur, later manifesting as multiple vesicular skin lesions involving the corneal and dermal skin layers 3. In the immunocompetent host this vesicular rash ultimately ruptures or is resorbed, and the primary infection is resolved, leaving behind protective antibody titers and cellular immunity 4. However, the virus remains latent in the spinal dorsal root ganglia and may reactivate in a dermatomal fashion to produce the syndrome of painful rash, the so called "Herpes Zoster" 5. Rarely, more severe primary infections may occur in adults, associated with significant morbidity 6. The most frequent sites of non-cutaneous severe involvement are the Central Nervous System (CNS), and neurological abnormalities may include cerebellar ataxia and encephalitis 7, 8. Varicella pneumonitis is another rare, life threatening complication of primary VZV infection. Other complications may include myocarditis, nephritis, bleeding diathesis, and hepatitis 9. Acute disseminated encephalomyelitis (ADEM) is a multifocal immune-mediated inflammatory disorder of the CNS characterized by widespread demyelination that predominantly involves the subcortical white matter of the brain and spinal cord 10. Most cases follow viral infection, and rarely vaccination, although a specific pathogen is not usually found. ADEM in immunocompetent adults is extremely rare, and is more common in children and immunosuppressed patients 11.
Here we present a case of a previously healthy 47 year old patient who presented with primary VZV infection and developed two major complications of VZV infection - pneumonitis and ADEM - after completing antiviral treatment for VZV.
A previously healthy, 47 year old patient, married with 4 children and employed as a radiologist was referred to our hospital suffering from severe respiratory distress.
During the month prior to admission three of the patient’s children had developed chickenpox infection (i.e., primary VZV infection). All four children were unvaccinated for VZV. The patient was also unvaccinated and has had no history of primary infection.A through history did not reveal any history suggestive of immunocompromise.
4 days prior to admission patient developed a persistent cough and nasal congestion. The following day a vesicular rash appeared on his chest and upper extremities. Two days later, patient started having difficulty breathing, and sought medical attention. Patient initially presented to the ER of an outside hospital, drowsy and with oxygen saturation levels of 75%. Patient was intubated and rapidly referred to the Medical Intensive Care Unit (MICU) in our hospital.
Patient was admitted while sedated and ventilated. Initial labs showed elevated inflammatory markers, with a leukocytosis of 21.5 X109/L, with neutrophilia and monocytosis. C-reactive protein (CRP) was 4.3 mg/DL (normal levels - 0 - 0.5mg/DL) and Lactate dehydrogenase (LDH) was 1946 U/L (normal levels 120-246 U/L). Kidney and liver function were normal. Chest X-ray demonstrated a diffuse nodular pattern and CT showed diffuse ground glass opacities and bilateral patchy infiltrates shown in Figure 1. Polymerase chain reaction from patient’s serum was positive for VZV.
A diagnosis of VZV pneumonitis was made and treatment with Acyclovir (10mg/kg/dose q8h) for 14 days was administered. Patient started improving gradually and was ultimately weaned off the ventilator. The patient, who had completed 14 days of Acyclovir treatment, was moved to the internal medical ward for further treatment.
On the ward, the patient was doing well, alert and oriented, communicating and moving all 4 extremities, though suffering from severe myopathy attributed to the protracted ventilation and ICU stay. He still required a small amount of supplemental oxygen. Obscure immunodeficiency was further assessed. Serologies for human immunodeficiency virus were negative and immunoglobulin levels were normal.
During one of the evenings, the on-call staff was urgently called to the patient due to decreased consciousness. Patients was found unresponsive, with normal vital signs. Pupils were dilated and non-responsive with a fixed left gaze and repetitive horizontal nystagmus. With a working diagnosis of seizure, patient was given IV diazepam, and when he failed to improve, was administered a loading dose of phenytoin. An urgent computerized tomography (CT) of the head demonstrated severe bilateral brain edema, mostly in the temporo-occipital regions as seen in Figure 2A&B. A brain magnetic resonance imaging (MRI) as shown in Figure 2C&D, revealed diffuse edema of both hemispheres and the cerebellum, with tiny bleeding foci.
The differential diagnosis for these findings consisted of ADEM, varicella zoster encephalitis and posterior reversible encephalopathy syndrome (PRES). While lumbar puncture was not performed due to the prohibitive brain edema, repeat blood PCR for VZV was negative. Patient was thus empirically treated for ADEM with pulse dose corticosteroids a plasmapheresis. A second course of Acyclovir was also started empirically and was stopped after negative blood PCR. Treatment produced a dramatic improvement in his condition and steroids were gradually tapered off.
The patient was later discharged to a rehabilitation facility and has since made a full neurological and respiratory recovery.
VZV pneumonitis is a life-threatening complication of varicella infection. It is responsible for the majority of morbidity and mortality of patients with varicella 12. The incidence of VZV pneumonitis in immunocompetent patients is 1:400 cases 13. In patients requiring mechanical ventilation, mortality rates reach almost 50% despite appropriate aggressive treatment 14.
VZV pneumonitis develops insidiously one to six days after cutaneous lesions appear. Usual symptoms include dry cough and dyspnea, with progressive hypoxemia developing. Chest imaging shows nodular component and diffuse bilateral infiltrates 15. Treatment includes prompt administration of intravenous acyclovir.
ADEM is an inflammatory process of the central nervous system affecting the brain and spinal cord. Although its pathogenesis is incompletely understood it appears to be an autoimmune disorder, triggered by an environmental stimulus in a genetically susceptible individual 16, 17. Histopathology of ADEM reveals perivascular infiltration of lymphocytes, and perivenous demyelination. The condition typically presents after a preceding viral infection, with herpes viruses being the most common triggers 18.
Diagnosis is based on imaging studies, most commonly an MRI showing multiple bilateral lesions in deep and subcortical white matter, hyperintense in T2, with variable gadolinium enhancement 19. Cerebrospinal findings may include lymphocytic pleocytosis with elevated or normal CSF protein 20. The diagnosis should be considered in patients with a multifocal neurological presentation following a viral infection.
Treatment is based on immunosuppression, most commonly high dose glucocorticoids, intravenous immunoglobulin treatment, or plasma exchange 21. Most adults with ADEM will improve with the treatment, with complete recovery in up to 40% of patients 22.
This case describes a patient who developed severe neurological symptoms after primary VZV infection. While definitive diagnosis is impossible, mainly due to the fact that a lumbar puncture was deemed prohibitively risky in this instance, the clinical course, MRI findings and dramatic reaction to treatment all support the probable diagnosis of ADEM.
To our knowledge, no previous cases have described both extra-cutaneous complications of primary VZV infection and a para-infectious neurological sequela seen in our case. The rarity of these conditions is underlined by the immunocompetent status of our patient, who has not had any suggestive events before, or - to the best of our knowledge - since.
[1] | Arvin, A. M. Varicella-zoster virus. Clin Microbiol Rev, 9, 3 (1996), 361-381. | ||
In article | View Article PubMed | ||
[2] | Gershon, A. A. and Silverstein, S. J. Varicella-zoster virus. American Society of Microbiology, City, 2009. | ||
In article | |||
[3] | Asano, Y., Itakura, N., Hiroishi, Y., Hirose, S., Nagai, T., Ozaki, T., Yazaki, T., Yamanishi, K. and Takahashi, M. Viremia is present in incubation period in nonimmunocompromised children with varicella. The Journal of pediatrics, 106, 1 (Jan 1985), 69-71. | ||
In article | View Article | ||
[4] | Laing, K. J., Ouwendijk, W. J. D., Koelle, D. M. and Verjans, G. M. G. M. Immunobiology of Varicella-Zoster Virus Infection. J Infect Dis, 218, suppl_2 (2018), S68-S74. | ||
In article | View Article PubMed | ||
[5] | Zerboni, L., Ku, C. C., Jones, C. D., Zehnder, J. L. and Arvin, A. M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proceedings of the National Academy of Sciences of the United States of America, 102, 18 (May 3 2005), 6490-6495. | ||
In article | View Article PubMed | ||
[6] | Paul, G., Paul, B. S. and Singh, G. Unseen face of varicella-zoster infection in adults. Indian J Crit Care Med, 20, 12 (2016), 731-734. | ||
In article | View Article PubMed | ||
[7] | Mustafa, M. B., Arduino, P. G. and Porter, S. R. Varicella zoster virus: review of its management. Journal of Oral Pathology & Medicine, 38, 9 (2009), 673-688. | ||
In article | View Article PubMed | ||
[8] | Tavazzi, E., Minoli, L., Ferrante, P., Scagnelli, P., Del Bue, S., Romani, A., Ravaglia, S. and Marchioni, E. Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient. Neurological Sciences, 29, 4 (2008/09/01 2008), 279-283. | ||
In article | View Article PubMed | ||
[9] | Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., Seward, J. F. and Yamanishi, K. Varicella zoster virus infection. Nat Rev Dis Primers, 1 (2015), 15016-15016. | ||
In article | View Article PubMed | ||
[10] | Tenembaum, S. N. Acute disseminated encephalomyelitis. Handb Clin Neurol, 112 (2013), 1253-1262. | ||
In article | View Article PubMed | ||
[11] | Dhar, J., Kumar, L., Ish, P. and Anuradha, S. Acute Disseminated Encephalomyelitis: A Rare Complication of Varicella Zoster Infection in an Adult. Journal of Clinical & Diagnostic Research, 12, 2 (2018). | ||
In article | View Article | ||
[12] | Marin, M., Watson, T. L., Chaves, S. S., Civen, R., Watson, B. M., Zhang, J. X., Perella, D., Mascola, L. and Seward, J. F. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis, 197 Suppl 2 (Mar 1 2008), S94-s100. | ||
In article | View Article PubMed | ||
[13] | Guess, H. A., Broughton, D. D., Melton, L. J., 3rd and Kurland, L. T. Population-based studies of varicella complications. Pediatrics, 78, 4 Pt 2 (Oct 1986), 723-727. | ||
In article | |||
[14] | Feldman, S. Varicella-zoster virus pneumonitis. Chest, 106, 1 Suppl (Jul 1994), 22s-27s. | ||
In article | View Article PubMed | ||
[15] | Floudas, C. S., Kanakis, M. A., Andreopoulos, A. and Vaiopoulos, G. A. Nodular lung calcifications following varicella zoster virus pneumonia. QJM: An International Journal of Medicine, 101, 2 (2008), 159-159. | ||
In article | View Article PubMed | ||
[16] | Pohl-Koppe, A., Burchett, S. K., Thiele, E. A. and Hafler, D. A. Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. Journal of neuroimmunology, 91, 1-2 (Nov 2 1998), 19-27. | ||
In article | View Article | ||
[17] | Stonehouse, M., Gupte, G., Wassmer, E. and Whitehouse, W. P. Acute disseminated encephalomyelitis: recognition in the hands of general paediatricians. Archives of disease in childhood, 88, 2 (Feb 2003), 122-124. | ||
In article | View Article PubMed | ||
[18] | Ketelslegers, I. A., Visser, I. E., Neuteboom, R. F., Boon, M., Catsman-Berrevoets, C. E. and Hintzen, R. Q. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Multiple sclerosis (Houndmills, Basingstoke, England), 17, 4 (Apr 2011), 441-448. | ||
In article | View Article PubMed | ||
[19] | Marin, S. E. and Callen, D. J. The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria. Neuroimaging clinics of North America, 23, 2 (May 2013), 245-266. | ||
In article | View Article PubMed | ||
[20] | Cole, J., Evans, E., Mwangi, M. and Mar, S. Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatric neurology, 100 (Nov 2019), 26-34. | ||
In article | View Article PubMed | ||
[21] | Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M. and Weinshenker, B. G. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology, 58, 1 (Jan 8 2002), 143-146. | ||
In article | View Article PubMed | ||
[22] | Schwarz, S., Mohr, A., Knauth, M., Wildemann, B. and Storch-Hagenlocher, B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology, 56, 10 (May 22 2001), 1313-1318. | ||
In article | View Article PubMed | ||
Published with license by Science and Education Publishing, Copyright © 2020 Assaf Potruch and Yuval Ishay
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
[1] | Arvin, A. M. Varicella-zoster virus. Clin Microbiol Rev, 9, 3 (1996), 361-381. | ||
In article | View Article PubMed | ||
[2] | Gershon, A. A. and Silverstein, S. J. Varicella-zoster virus. American Society of Microbiology, City, 2009. | ||
In article | |||
[3] | Asano, Y., Itakura, N., Hiroishi, Y., Hirose, S., Nagai, T., Ozaki, T., Yazaki, T., Yamanishi, K. and Takahashi, M. Viremia is present in incubation period in nonimmunocompromised children with varicella. The Journal of pediatrics, 106, 1 (Jan 1985), 69-71. | ||
In article | View Article | ||
[4] | Laing, K. J., Ouwendijk, W. J. D., Koelle, D. M. and Verjans, G. M. G. M. Immunobiology of Varicella-Zoster Virus Infection. J Infect Dis, 218, suppl_2 (2018), S68-S74. | ||
In article | View Article PubMed | ||
[5] | Zerboni, L., Ku, C. C., Jones, C. D., Zehnder, J. L. and Arvin, A. M. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proceedings of the National Academy of Sciences of the United States of America, 102, 18 (May 3 2005), 6490-6495. | ||
In article | View Article PubMed | ||
[6] | Paul, G., Paul, B. S. and Singh, G. Unseen face of varicella-zoster infection in adults. Indian J Crit Care Med, 20, 12 (2016), 731-734. | ||
In article | View Article PubMed | ||
[7] | Mustafa, M. B., Arduino, P. G. and Porter, S. R. Varicella zoster virus: review of its management. Journal of Oral Pathology & Medicine, 38, 9 (2009), 673-688. | ||
In article | View Article PubMed | ||
[8] | Tavazzi, E., Minoli, L., Ferrante, P., Scagnelli, P., Del Bue, S., Romani, A., Ravaglia, S. and Marchioni, E. Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient. Neurological Sciences, 29, 4 (2008/09/01 2008), 279-283. | ||
In article | View Article PubMed | ||
[9] | Gershon, A. A., Breuer, J., Cohen, J. I., Cohrs, R. J., Gershon, M. D., Gilden, D., Grose, C., Hambleton, S., Kennedy, P. G. E., Oxman, M. N., Seward, J. F. and Yamanishi, K. Varicella zoster virus infection. Nat Rev Dis Primers, 1 (2015), 15016-15016. | ||
In article | View Article PubMed | ||
[10] | Tenembaum, S. N. Acute disseminated encephalomyelitis. Handb Clin Neurol, 112 (2013), 1253-1262. | ||
In article | View Article PubMed | ||
[11] | Dhar, J., Kumar, L., Ish, P. and Anuradha, S. Acute Disseminated Encephalomyelitis: A Rare Complication of Varicella Zoster Infection in an Adult. Journal of Clinical & Diagnostic Research, 12, 2 (2018). | ||
In article | View Article | ||
[12] | Marin, M., Watson, T. L., Chaves, S. S., Civen, R., Watson, B. M., Zhang, J. X., Perella, D., Mascola, L. and Seward, J. F. Varicella among adults: data from an active surveillance project, 1995-2005. J Infect Dis, 197 Suppl 2 (Mar 1 2008), S94-s100. | ||
In article | View Article PubMed | ||
[13] | Guess, H. A., Broughton, D. D., Melton, L. J., 3rd and Kurland, L. T. Population-based studies of varicella complications. Pediatrics, 78, 4 Pt 2 (Oct 1986), 723-727. | ||
In article | |||
[14] | Feldman, S. Varicella-zoster virus pneumonitis. Chest, 106, 1 Suppl (Jul 1994), 22s-27s. | ||
In article | View Article PubMed | ||
[15] | Floudas, C. S., Kanakis, M. A., Andreopoulos, A. and Vaiopoulos, G. A. Nodular lung calcifications following varicella zoster virus pneumonia. QJM: An International Journal of Medicine, 101, 2 (2008), 159-159. | ||
In article | View Article PubMed | ||
[16] | Pohl-Koppe, A., Burchett, S. K., Thiele, E. A. and Hafler, D. A. Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. Journal of neuroimmunology, 91, 1-2 (Nov 2 1998), 19-27. | ||
In article | View Article | ||
[17] | Stonehouse, M., Gupte, G., Wassmer, E. and Whitehouse, W. P. Acute disseminated encephalomyelitis: recognition in the hands of general paediatricians. Archives of disease in childhood, 88, 2 (Feb 2003), 122-124. | ||
In article | View Article PubMed | ||
[18] | Ketelslegers, I. A., Visser, I. E., Neuteboom, R. F., Boon, M., Catsman-Berrevoets, C. E. and Hintzen, R. Q. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Multiple sclerosis (Houndmills, Basingstoke, England), 17, 4 (Apr 2011), 441-448. | ||
In article | View Article PubMed | ||
[19] | Marin, S. E. and Callen, D. J. The magnetic resonance imaging appearance of monophasic acute disseminated encephalomyelitis: an update post application of the 2007 consensus criteria. Neuroimaging clinics of North America, 23, 2 (May 2013), 245-266. | ||
In article | View Article PubMed | ||
[20] | Cole, J., Evans, E., Mwangi, M. and Mar, S. Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. Pediatric neurology, 100 (Nov 2019), 26-34. | ||
In article | View Article PubMed | ||
[21] | Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M. and Weinshenker, B. G. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology, 58, 1 (Jan 8 2002), 143-146. | ||
In article | View Article PubMed | ||
[22] | Schwarz, S., Mohr, A., Knauth, M., Wildemann, B. and Storch-Hagenlocher, B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology, 56, 10 (May 22 2001), 1313-1318. | ||
In article | View Article PubMed | ||